Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
Emmanuel Velazquez-Alvarez, Product Manager at Technoclone, shared a post on LinkedIn:
“Diagnostics is indeed a very dynamic area, with significant advances in automation, assay sensitivity, and data integration.
From my perspective, one of the main challenges remains translating technological innovation into routine clinical workflows.
Factors such as standardization across laboratories, regulatory requirements, cost effectiveness, and clinician familiarity can often slow adoption despite clear technical benefits.
Bridging that gap while maintaining diagnostic accuracy and supporting faster clinical decisions will continue to be a key focus for the field.
It was inspiring to meet and exchange ideas with colleagues, researchers, clinicians, and leading experts from around the world who are shaping the future of thrombosis, hemostasis, and healthcare innovation.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question